Mid-Year Report

THE HOBBS GROUP, LLC for JOHNSON & JOHNSON

Firm
Client
Income
$120,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Proposed CMS national coverage decisions for the use of erythropoiesis stimulating agents (ESAs) in cancer and related neoplastic conditions, on privately-sponsored post-approval clinical trials, and the Inpatient Prospective Payment System.

LobbyistCovered position, as disclosed
DAVID HOBBS ASSISTANT TO THE PRESIDENT FOR LEGISLATIVE AFFAIR

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Office of Management & Budget (OMB)

Taxation/Internal Revenue Code TAX

H.R.2138 - The Investment in America Act of 2007 S.41 - The Research Competitiveness Act of 2007

LobbyistCovered position, as disclosed
DAVID HOBBS ASSISTANT TO THE PRESIDENT FOR LEGISLATIVE AFFAIR

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP); Office of Management & Budget (OMB)

Bills named: S. 41 (110th), H.R. 2138 (110th)

Health Issues HCR

Proposed CMS national coverage decisions for the use of erythropoiesis stimulating agents (ESAs) in cancer and related neoplastic conditions, on privately-sponsored post-approval clinical trials, and the Inpatient Prospective Payment System.

LobbyistCovered position, as disclosed
DAVID HOBBS ASSISTANT TO THE PRESIDENT FOR LEGISLATIVE AFFAIR

Contacted: Office of Management & Budget (OMB); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.